Palvella Therapeutics, Inc. (PVLA) vs Sarepta Therapeutics, Inc. (SRPT)

A side-by-side comparison of Palvella Therapeutics, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PVLA vs SRPT

growth of $100 · dividends reinvested · last 2y
PVLA +677.4% (+178.8%/yr)SRPT -86.1% (-62.7%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$777$14
PVLA SRPT

PVLA vs SRPT: by the numbers

  • •PVLA is the larger company ($1.84B vs $1.83B market cap).
  • •Both run net losses; PVLA's is the smaller (0.00% vs -6.93% net margin).

Metrics side by side

Valuation

MetricPVLASRPT
Forward P/EN/A5.38
P/S ratioN/A0.93
P/B ratio8.471.20

Profitability

MetricPVLASRPT
Gross margin0.00%58.56%
Operating margin0.00%-29.92%
Net margin0.00%-6.93%
ROE-28.45%-8.95%
ROIC-23.90%-5.33%

Growth (annualized)

MetricPVLASRPT
Revenue CAGR (5Y)N/A26.90%
Total return CAGR (5Y)N/A-28.74%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.